Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2008) - Comments
pubmed: 18520805  doi: 10.1097/jto.0b013e3181753b24  issn: 1556-0864  issn: 1556-1380 

Tianhong Li, Yi-He Ling, Roman Perez-Soler